What will be the hot clinical topics in IBD in 2016?

What have practitioners learned from the first wave of COVID-19 that can be applied to the treatment of patients with autoimmune rheumatic conditions during this next wave? Michael George, MD, discusses in...

David R. Nelson, MD, discusses future developments to HCV treatment strategies and methods, and how they will affect the standard of care.

In his last video, Garret Duron, MD, explained which questions rheumatologists can ask themselves when determining whether a piece of COVID-19 literature will be helpful to them. But what information would...